Phase 1 Dose Escalation and Drug Distribution Study of Oral Terameprocol in Patients With Recurrent High Grade Glioma
Not yet recruiting
Phase of Trial: Phase I
Latest Information Update: 17 Nov 2017
At a glance
- Drugs Terameprocol (Primary)
- Indications Glioma
- Focus Adverse reactions; Pharmacokinetics
- 09 Nov 2017 Planned initiation date changed from 1 Jul 2017 to 31 Dec 2017.
- 09 Nov 2017 Status changed from suspended to not yet recruiting.
- 08 Dec 2016 Planned primary completion date changed from 1 Dec 2018 to 1 Dec 2021.